Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages
Wenyun Zeng, Danbin Wu, Yingxin Sun, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 598
Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes
Ankit Pandeya, Thirumala‐Devi Kanneganti
Trends in Molecular Medicine (2023) Vol. 30, Iss. 1, pp. 74-88
Open Access | Times Cited: 83
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 4
Open Access | Times Cited: 59
Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets
Guido R.Y. De Meyer, Michelle Zurek, Pauline Puylaert, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 5, pp. 312-325
Closed Access | Times Cited: 58
New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation
Triveni Kodi, Runali Sankhe, Adarsh Gopinathan, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Chad Stroope, Felix Sebastian Nettersheim, Brian G. Coon, et al.
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 617-638
Open Access | Times Cited: 21
Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis
María A. Zuriaga, Zhi Yu, Nuria Matesanz, et al.
European Heart Journal (2024)
Open Access | Times Cited: 19
Combination therapies and other therapeutic approaches targeting the NLRP3 inflammasome and neuroinflammatory pathways: a promising approach for traumatic brain injury
Zana Montazeri-Khosh, Ahmad Ebrahimpour, Mina Keshavarz, et al.
Immunopharmacology and Immunotoxicology (2025), pp. 1-17
Closed Access | Times Cited: 2
New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
Lan-Lan Bu, Huanhuan Yuan, Lingli Xie, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15160-15160
Open Access | Times Cited: 42
Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization
Zedazhong Su, Chunqiu Li, Huawei Wang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 41
Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases
Ying‐Hao Han, Xiaodong Liu, Meihua Jin, et al.
Inflammation Research (2023) Vol. 72, Iss. 9, pp. 1839-1859
Closed Access | Times Cited: 34
Role of pyroptosis in the pathogenesis and treatment of diseases
Xiangyu Jin, Yinchu Ma, Didi Liu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 31
Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome
Xiaonan Zhang, Zeping Wang, Xiaoya Li, et al.
Journal of Ethnopharmacology (2023) Vol. 309, pp. 116304-116304
Closed Access | Times Cited: 27
Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
Daniela Maria Tănase, Emilia Valasciuc, Evelina Maria Gosav, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8162-8162
Open Access | Times Cited: 27
Challenges and advances in the management of inflammation in atherosclerosis
Yiming Xing, Xianhe Lin
Journal of Advanced Research (2024)
Open Access | Times Cited: 13
The role of immune system in atherosclerosis: Molecular mechanisms, controversies, and future possibilities
Tianle Zhang, Chenxu Pang, Mengxin Xu, et al.
Human Immunology (2024) Vol. 85, Iss. 2, pp. 110765-110765
Closed Access | Times Cited: 9
Recent advances in targeted therapy for inflammatory vascular diseases
Kaiwen Zhao, Zan Zeng, Yuzhen He, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 730-750
Closed Access | Times Cited: 9
Recent progress of endoplasmic reticulum stress in the mechanism of atherosclerosis
Lin Ni, Luqun Yang, Yuanyuan Lin
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 9
Cytokines are the Basis of the Development and Suppression of Inflammation in Atherosclerosis
Alexander V. Blagov, Alexey V. Churov, I. Starodubtseva, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access | Times Cited: 1
Probenecid Inhibits NLRP3 Inflammasome Activity and Mitogen-Activated Protein Kinases (MAPKs)
Les Jones, David E. Martin, Jackelyn Murray, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 511-511
Open Access | Times Cited: 1
Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target
Khadija El Hadri, Rémy Smith, Eric Duplus, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 77-77
Open Access | Times Cited: 53
Pyroptosis-Mediated Periodontal Disease
Mariane Beatriz Sordi, Ricardo de Souza Magini, Layla Panahipour, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 372-372
Open Access | Times Cited: 51
The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches
Panagiotis Tsioufis, Panagiotis Theofilis, Konstantinos Tsioufis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15937-15937
Open Access | Times Cited: 37
Gasdermin D Deficiency Limits the Transition of Atherosclerotic Plaques to an Inflammatory Phenotype in ApoE Knock-Out Mice
Pauline Puylaert, Melissa Van Praet, Frederik Vaes, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1171-1171
Open Access | Times Cited: 36
Activation of NLRP3 inflammasome contributes to the inflammatory response to allergic rhinitis via macrophage pyroptosis
Huiqin Zhou, Wei Zhang, Danxue Qin, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109012-109012
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top